1. Home
  2. MERC vs ALT Comparison

MERC vs ALT Comparison

Compare MERC & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MERC
  • ALT
  • Stock Information
  • Founded
  • MERC 1968
  • ALT 1997
  • Country
  • MERC Canada
  • ALT United States
  • Employees
  • MERC N/A
  • ALT N/A
  • Industry
  • MERC Paper
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • MERC Basic Materials
  • ALT Health Care
  • Exchange
  • MERC Nasdaq
  • ALT Nasdaq
  • Market Cap
  • MERC 468.8M
  • ALT 472.3M
  • IPO Year
  • MERC 1987
  • ALT N/A
  • Fundamental
  • Price
  • MERC $6.15
  • ALT $5.00
  • Analyst Decision
  • MERC Hold
  • ALT Strong Buy
  • Analyst Count
  • MERC 2
  • ALT 8
  • Target Price
  • MERC $7.75
  • ALT $21.00
  • AVG Volume (30 Days)
  • MERC 338.0K
  • ALT 3.0M
  • Earning Date
  • MERC 05-08-2025
  • ALT 05-08-2025
  • Dividend Yield
  • MERC 4.87%
  • ALT N/A
  • EPS Growth
  • MERC N/A
  • ALT N/A
  • EPS
  • MERC N/A
  • ALT N/A
  • Revenue
  • MERC $2,043,360,000.00
  • ALT $20,000.00
  • Revenue This Year
  • MERC $3.26
  • ALT N/A
  • Revenue Next Year
  • MERC $5.78
  • ALT N/A
  • P/E Ratio
  • MERC N/A
  • ALT N/A
  • Revenue Growth
  • MERC 2.48
  • ALT N/A
  • 52 Week Low
  • MERC $5.33
  • ALT $4.78
  • 52 Week High
  • MERC $11.20
  • ALT $11.16
  • Technical
  • Relative Strength Index (RSI)
  • MERC 38.81
  • ALT 35.19
  • Support Level
  • MERC $6.45
  • ALT $5.60
  • Resistance Level
  • MERC $6.78
  • ALT $6.16
  • Average True Range (ATR)
  • MERC 0.24
  • ALT 0.35
  • MACD
  • MERC -0.05
  • ALT -0.02
  • Stochastic Oscillator
  • MERC 27.17
  • ALT 15.94

About MERC Mercer International Inc.

Mercer International Inc is a forest products company with two reportable operating segments in pulp and solid wood. The pulp segment consists of the manufacture, sale, and distribution of pulp, electricity, and chemicals. The company has a geographical presence in the USA, Germany, China, and Other countries, where the majority of revenue is generated from the USA. The majority of the revenue is generated from the Pulp segment.

About ALT Altimmune Inc.

Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

Share on Social Networks: